Case and Research Letter
Quinacrine: A Treatment Option That Should Not Be Overlooked
Quinacrina, un escalón terapéutico que no debemos obviar
P. García-Montero
, J. del Boz, J.F. Millán-Cayetano, M. de Troya-Martín
Corresponding author
Departamento de Dermatología, Hospital Costa del Sol, Marbella, Málaga, Spain
Read
16322
Timeswas read the article
2553
Total PDF
13769
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 101 | 8 | 109 |
| 2025 5 | 615 | 51 | 666 |
| 2025 4 | 593 | 31 | 624 |
| 2025 3 | 582 | 30 | 612 |
| 2025 2 | 481 | 43 | 524 |
| 2025 1 | 401 | 38 | 439 |
| 2024 12 | 440 | 32 | 472 |
| 2024 11 | 342 | 53 | 395 |
| 2024 10 | 304 | 55 | 359 |
| 2024 9 | 306 | 44 | 350 |
| 2024 8 | 337 | 61 | 398 |
| 2024 7 | 394 | 50 | 444 |
| 2024 6 | 294 | 61 | 355 |
| 2024 5 | 290 | 42 | 332 |
| 2024 4 | 283 | 40 | 323 |
| 2024 3 | 340 | 48 | 388 |
| 2024 2 | 328 | 35 | 363 |
| 2024 1 | 338 | 45 | 383 |
| 2023 12 | 322 | 34 | 356 |
| 2023 11 | 316 | 31 | 347 |
| 2023 10 | 292 | 34 | 326 |
| 2023 9 | 227 | 35 | 262 |
| 2023 8 | 192 | 28 | 220 |
| 2023 7 | 230 | 28 | 258 |
| 2023 6 | 257 | 32 | 289 |
| 2023 5 | 210 | 30 | 240 |
| 2023 4 | 254 | 22 | 276 |
| 2023 3 | 255 | 40 | 295 |
| 2023 2 | 187 | 30 | 217 |
| 2023 1 | 197 | 33 | 230 |
| 2022 12 | 124 | 47 | 171 |
| 2022 11 | 81 | 35 | 116 |
| 2022 10 | 91 | 29 | 120 |
| 2022 9 | 65 | 43 | 108 |
| 2022 8 | 43 | 36 | 79 |
| 2022 7 | 40 | 59 | 99 |
| 2022 6 | 41 | 39 | 80 |
| 2022 5 | 172 | 31 | 203 |
| 2022 4 | 230 | 31 | 261 |
| 2022 3 | 157 | 50 | 207 |
| 2022 2 | 166 | 37 | 203 |
| 2022 1 | 226 | 57 | 283 |
| 2021 12 | 116 | 33 | 149 |
| 2021 11 | 158 | 50 | 208 |
| 2021 10 | 146 | 54 | 200 |
| 2021 9 | 129 | 47 | 176 |
| 2021 8 | 120 | 56 | 176 |
| 2021 7 | 134 | 21 | 155 |
| 2021 6 | 169 | 31 | 200 |
| 2021 5 | 130 | 38 | 168 |
| 2021 4 | 396 | 87 | 483 |
| 2021 3 | 119 | 25 | 144 |
| 2021 2 | 57 | 35 | 92 |
| 2021 1 | 37 | 24 | 61 |
| 2020 12 | 50 | 17 | 67 |
| 2020 11 | 31 | 23 | 54 |
| 2020 10 | 35 | 13 | 48 |
| 2020 9 | 35 | 16 | 51 |
| 2020 8 | 27 | 22 | 49 |
| 2020 7 | 16 | 17 | 33 |
| 2020 6 | 29 | 31 | 60 |
| 2020 5 | 21 | 14 | 35 |
| 2020 4 | 24 | 18 | 42 |
| 2020 3 | 19 | 17 | 36 |
| 2020 2 | 1 | 0 | 1 |
| 2019 12 | 4 | 0 | 4 |
| 2019 10 | 1 | 0 | 1 |
| 2019 9 | 5 | 0 | 5 |
| 2019 8 | 2 | 0 | 2 |
| 2019 7 | 4 | 0 | 4 |
| 2019 5 | 2 | 1 | 3 |
| 2019 4 | 4 | 3 | 7 |
| 2019 2 | 4 | 0 | 4 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 1 | 0 | 1 |
| 2018 11 | 10 | 0 | 10 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 1 | 0 | 1 |
| 2018 4 | 2 | 0 | 2 |
| 2018 2 | 34 | 3 | 37 |
| 2018 1 | 62 | 18 | 80 |
| 2017 12 | 56 | 9 | 65 |
| 2017 11 | 46 | 7 | 53 |
| 2017 10 | 39 | 7 | 46 |
| 2017 9 | 24 | 12 | 36 |
| 2017 8 | 35 | 8 | 43 |
| 2017 7 | 34 | 7 | 41 |
| 2017 6 | 35 | 10 | 45 |
| 2017 5 | 27 | 7 | 34 |
| 2017 4 | 37 | 26 | 63 |
| 2017 3 | 25 | 21 | 46 |
| 2017 2 | 22 | 8 | 30 |
| 2017 1 | 22 | 13 | 35 |
| 2016 12 | 61 | 36 | 97 |
| 2016 11 | 21 | 27 | 48 |
| 2016 10 | 1 | 3 | 4 |
Show all
